Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
EWEdwards Lifesciences Corp Live data
$86.83▲ +0.54 (0.6%%)as of Sep 29, 2026, 1:55 AM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$72.30$96.29
Daily Price Range
Day up 0.6%%
$85.56$87.33
Volume
vs 3M avg
3M3M avg
Profile
Identity and capital structure
SectorEquity
IndustryCommon Stock
Market Cap$50.0B
Short % of Float—
Employees—
Sales—
Shares Outstanding576,413,682
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.ew.com
Edwards Lifesciences Corp — Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; ….· via yahoo
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for EW.
Price targets unavailable — no 12-month targets on file for EW.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on EW, calculate Margin of Safety, and stress-test WACC discount hurdles.
Data as ofQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedSep 29, 2026, 1:55 AM UTC